Strategies for Addressing Resistance and Off-Target Toxicity in Antibody-Drug ConjugatesFebruary 24, 2026
Longevity Scienta’s new AI model targets aging-linked inflammationBy adminFebruary 24, 20260 New AI model EVA accelerates drug discovery in inflammation, bridging preclinical research to real-world patient therapies. Drug discovery is always…
